068270.KS
Price:
$183300
Market Cap:
$40.10T
Celltrion, Inc., together with its subsidiaries, develops and produces therapeutics based on proteins including oncology treatment drugs in South Korea. The company markets Remsima, Truxima, and Herzuma products; generic pharmaceuticals; covid-19 test kits. Its antibody biosimilar pipeline includes CT-P39 for the treatment of asthma and urticaria that is in phase 1 clinical trial; CT-P17 for the treatment of rheumatoid arthritis, psoriatic arthritis, and IBD, which is in phase 3 clinical trial; CT-P16 for the treatment of metastatic colorectal cancer and breast cancer that is in phase 3 clinical trial; CT-P41 for the treatment of osteoporosis and bone loss, which is in phase 1 clinical trial...[Read more]
Industry
Biotechnology
IPO Date
2005-07-19
Stock Exchange
KSC
Ticker
068270.KS
According to Celltrion, Inc.’s latest financial reports and current stock price. The company's current ROE is 2.90%. This represents a change of 303.78% compared to the average of 0.72% of the last 4 quarters.
The mean historical ROE of Celltrion, Inc. over the last ten years is 10.37%. The current 2.90% ROE has changed -72.07% with respect to the historical average. Over the past ten years (40 quarters), 068270.KS's ROE was at its highest in in the March 2021 quarter at 5.58%. The ROE was at its lowest in in the December 2023 quarter at 0.01%.
Average
10.37%
Median
10.40%
Minimum
2.42%
Maximum
16.10%
Discovering the peaks and valleys of Celltrion, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 85.73%
Maximum Annual ROE = 16.10%
Minimum Annual Increase = -75.72%
Minimum Annual ROE = 2.42%
| Year | ROE | Change |
|---|---|---|
| 2024 | 2.42% | -23.16% |
| 2023 | 3.15% | -75.72% |
| 2022 | 12.99% | -12.16% |
| 2021 | 14.79% | -5.50% |
| 2020 | 15.65% | 43.52% |
| 2019 | 10.91% | 10.35% |
| 2018 | 9.88% | -38.60% |
| 2017 | 16.10% | 85.73% |
| 2016 | 8.67% | -4.70% |
| 2015 | 9.09% | 0.69% |
The current ROE of Celltrion, Inc. (068270.KS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
6.19%
5-year avg
9.80%
10-year avg
10.37%
Celltrion, Inc.’s ROE is greater than GeneOne Life Science, Inc. (-64.58%), less than ALTEOGEN Inc. (32.44%), greater than SK bioscience Co.,Ltd. (-2.96%), less than SK Biopharmaceuticals Co., Ltd. (50.02%), greater than Genexine, Inc. (-29.56%), greater than D&D Pharmatech (-53.26%), greater than SillaJen, Inc. (-19.38%), greater than Voronoi, Inc. (-71.31%), greater than OliX Pharmaceuticals,Inc (-219.97%), greater than Peptron, Inc. (-14.57%),
| Company | ROE | Market cap |
|---|---|---|
| -64.58% | $175.34B | |
| 32.44% | $24.40T | |
| -2.96% | $4.23T | |
| 50.02% | $10.49T | |
| -29.56% | $229.22B | |
| -53.26% | $4.16T | |
| -19.38% | $531.80B | |
| -71.31% | $4.28T | |
| -219.97% | $2.37T | |
| -14.57% | $6.62T |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celltrion, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Celltrion, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Celltrion, Inc.'s ROE?
How is the ROE calculated for Celltrion, Inc. (068270.KS)?
What is the highest ROE for Celltrion, Inc. (068270.KS)?
What is the 3-year average ROE for Celltrion, Inc. (068270.KS)?
What is the 5-year average ROE for Celltrion, Inc. (068270.KS)?
How does the current ROE for Celltrion, Inc. (068270.KS) compare to its historical average?